Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Bone and Mineral Metabolism
Metadata
Title
Cbfa1, a transcription factor for osteoblast differentiation and bone formation
Author
Toshihisa Komori
Publication date
01-03-1998
Publisher
Springer-Verlag
Published in
Journal of Bone and Mineral Metabolism / Issue 1/1998
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s007740050020

Other articles of this Issue 1/1998

Journal of Bone and Mineral Metabolism 1/1998 Go to the issue

Original articles

23(S)25(R)-1,25-Dihydroxyvitamin D3-lactone, a naturally occurring metabolite of 1,25-dihydroxyvitamin D3, inhibits osteoclast-like cell formation in human bone marrow cultures

OriginalPaper

Measurement of vertebral body dimensions of the thoracic and lumbar spines of 242 healthy women

OriginalPaper

Efficacy and safety of long-term oral falecalcitriol treatment in patients with renal osteodystrophy

OriginalPaper

The N-terminal fragment of osteocalcin is released during osteoclastic bone resorption in vitro

OriginalPaper

Comparison of effects of estriol on bone mineral density of vertebrae between elderly and postmenopausal women

OriginalPaper

Efficacy and safety of oral falecalcitriol in reducing parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits